The GLP is committed to full transparency. Download and review our Annual Report.

Data-driven medicine: understanding the link between genetics and disease

| | October 17, 2013

From Google to Facebook and GCHQ to the NSA, every day we hear more about the lengths to which organizations are going to get their hands on our precious data.

Retail, advertising, manufacturing, transport, energy, local government, charity – whichever sector you care to look at, data is playing an increasingly important role in our society and economy. While many people view this as an invasion of their privacy, the majority of this data is anonymous and contributes to genuinely valuable research.

The Wellcome Sanger Institute, which was the single largest contributor to the Human Genome Project, is now using so-called ‘big data’ to investigate the genetic make-up of some of the most common causes of premature death.

Read the full, original story here: Data-driven medicine: understanding the link between genetics and disease

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend